Click here for more information about the Children's Cancer Association
The Portland Trail Blazers have teamed up for a fourth year with Genentech and the Children's Cancer Association (CCA) for the Block Out Cancer campaign. As part of the program, Genentech donates $25 to CCA each time the Trail Blazers block a shot. Last season, Genentech and the Make It Better Foundation made a combined donation of $15,000 to CCA. The Trail Blazers also lent an assist with an additional grant to CCA. Funds raised through the Block Out Cancer campaign support CCA's innovative programs of JoyRx that help children, teens and their families who are battling cancer and other serious illnesses. When families need support, CCA is there with award-winning programs and resources, available at no cost to those in need, in Oregon and SW Washington.
Keep checking back to see how many shots the Trail Blazers have blocked this year for CCA!
When seriously ill children and their families need more than medicine, CCA's innovative programs create joy one moment at a time.
We prescribe joy.
For children diagnosed with serious illness and their families, every moment is precious. At CCA, our goal is to transform as many of those moments as possible — with joy.
Because in the fight against devastating illness, joy is often forgotten. Because joy connects us with the power of hope, comfort, and happiness and helps families and children feel uplifted when their lives have been turned upside down. Because joy is something every child deserves.
Unlike many organizations dedicated to the worthy goal of someday finding a cure for cancer, CCA is all about today. We specialize on the moment, delivering immediate help to kids and teens facing life-threatening illness. We long for the day when there's a cure for cancer; but until that day arrives, we're there for kids facing the biggest battle of their lives who need our help, today.
Learn more about CCA and how to get involved by visiting www.JoyRx.org
Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life- threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about Genentech, please visit http://www.gene.com